In this article, we want to point out our attention to CMDs belonging to the group of dystroglycanopathies (also reported as alpha-dystroglycan related MDs) [2] and in particular on clinical features of the most severe disorders of this group: FCMD, MEB disease, and WWS. The gene discussed is DAG1; the disease is muscular dystrophy-dystroglycanopathy, type A.